MLX
Device
NUVASIVE, INC.
Total Payments
$397,412
Transactions
427
Doctors
208
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $41,501 | 20 | 10 |
| 2023 | $39,225 | 28 | 20 |
| 2022 | $29,281 | 26 | 13 |
| 2021 | $33,941 | 21 | 8 |
| 2020 | $65,236 | 34 | 18 |
| 2019 | $41,215 | 56 | 39 |
| 2018 | $75,292 | 98 | 51 |
| 2017 | $71,722 | 144 | 102 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $289,640 | 76 | 72.9% |
| Consulting Fee | $32,650 | 9 | 8.2% |
| Unspecified | $29,036 | 13 | 7.3% |
| Travel and Lodging | $16,421 | 21 | 4.1% |
| Food and Beverage | $15,992 | 301 | 4.0% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $13,250 | 1 | 3.3% |
| Education | $422.64 | 6 | 0.1% |
Payments by Type
General
$368,376
414 transactions
Research
$29,036
13 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| NUVA.EXP0120 An Assessment of the Safety and Performance of the MLX Medial Lateral and XLX ACR Expandable Lumbar Interbody Implants for the Treatment of Patients with Degenerative Conditions of the Thoracic and/or Lumbar Spine | NuVasive, Inc. | $26,721 | 0 |
| NUVA.EXP0120: An Assessment of the Safety and Performance of the MLX Medial Lateral and XLX ACR Expandable Lumbar Interbody Implants for the Treatment of Patients with Degenerative Conditions of the Thoracic and/or Lumbar Spine | NuVasive, Inc. | $1,475 | 0 |
| An Assessment of the Safety and Performance of the MLX Medial Lateral and XLX ACR Expandable Lumbar Interbody Implants for the Treatment of Patients With Degenerative Conditions of the Thoracic and/or Lumbar Spine | NuVasive, Inc. | $840.00 | 0 |
Top Doctors Receiving Payments for MLX — Page 3
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Neurological Surgery | Houston, TX | $112.79 | 1 |
| , MD | Neurological Surgery | Houston, TX | $112.79 | 1 |
| , M.D | Neurological Surgery | Philadelphia, PA | $112.79 | 1 |
| , MD | Neurological Surgery | Jacksonville, FL | $112.79 | 1 |
| , MD | Neurological Surgery | Houston, TX | $112.79 | 1 |
| , M.D | Neurological Surgery | Somerset, KY | $112.79 | 1 |
| , M.D | Neurological Surgery | The Woodlands, TX | $112.79 | 1 |
| , M.D | Neurological Surgery | Houston, TX | $112.79 | 1 |
| , MD | Neurological Surgery | Cincinnati, OH | $112.79 | 1 |
| Awais Vance | Neurological Surgery | Dallas, TX | $112.79 | 1 |
| , M.D | Neurological Surgery | Galveston, TX | $112.79 | 1 |
| , MD | Neurological Surgery | Houston, TX | $112.79 | 1 |
| , M.D | Neurological Surgery | Houston, TX | $112.79 | 1 |
| , MD | Neurological Surgery | Houston, TX | $112.79 | 1 |
| , MD | Neurological Surgery | Miami, FL | $112.78 | 1 |
| , M.D | Neurological Surgery | Houston, TX | $112.78 | 1 |
| , MD | Neurological Surgery | St. Paul, MN | $112.78 | 1 |
| , M.D | Neurological Surgery | Houston, TX | $112.78 | 1 |
| , MD | Orthopaedic Surgery | Commack, NY | $112.34 | 2 |
| , M.D | Neurological Surgery | Stanford, CA | $108.66 | 1 |
| , MD | Neurological Surgery | Boise, ID | $106.96 | 2 |
| , MD | Neurological Surgery | Jacksonville, FL | $106.19 | 1 |
| , M.D | Orthopaedic Surgery | Naperville, IL | $105.95 | 1 |
| , MD | Neurological Surgery | Fresno, CA | $100.22 | 1 |
| , M.D | Neurological Surgery | West Islip, NY | $97.00 | 1 |
Ad
Manufacturing Companies
- NuVasive, Inc. $284,190
- NUVASIVE, INC. $71,722
- Globus Medical, Inc. $41,501
Product Information
- Type Device
- Total Payments $397,412
- Total Doctors 208
- Transactions 427
About MLX
MLX is a device associated with $397,412 in payments to 208 healthcare providers, recorded across 427 transactions in the CMS Open Payments database. The primary manufacturer is NUVASIVE, INC..
Payment data is available from 2017 to 2024. In 2024, $41,501 was paid across 20 transactions to 10 doctors.
The most common payment nature for MLX is "Royalty or License" ($289,640, 72.9% of total).
MLX is associated with 3 research studies, including "NUVA.EXP0120 An Assessment of the Safety and Performance of the MLX Medial Lateral and XLX ACR Expandable Lumbar Interbody Implants for the Treatment of Patients with Degenerative Conditions of the Thoracic and/or Lumbar Spine" ($26,721).